PMV

Dr. Veronika Lappe MPH

>Research associate

Phone 0221 478-85534
veronika.lappe_at_uk-koeln.de

Short biography

1984 until 1989 | Study of pharmacy at the Ludwig-Maximilians-University Munich, licence to practise pharmacy

1989 until 1999 | Employed pharmacist in various public pharmacies

1990 until 1993 | Independent management of a public pharmacy

1994 until 1996 | Postgraduate course in Public Health and Epidemiology. LMU Munich. Master of Public Health (MPH)

1999 | Doctorate as Dr. rer. hum. biol. at the Medical Faculty of the LMU Munich
Topic: »The prophylaxis of neural tube defects by folic acid: putting a medical research result into practice«

1999 until 2001 | Research associate in the research project »Pegasus« on drug intake during pregnancy at the Bavarian Research Association for Public Health

2001 until 2004 | Research associate in a study of the German Research Foundation (DFG): »Analysis of health insurance data on drug prescription in pregnancy«

Since 2005 | Research associate at PMV research group

Work focus

  • Drug application research (pharmacoepidemiology)
  • Evaluation of drug and health data of the statutory health insurance
  • Health Services Research

Memberships

  • Society for Drug Application Research and Drug Epidemiology (GAA)
  • German Society for Epidemiology (DGEpi)

Selected Publications

Grandt D, Lappe V, Schubert I (Hrsg.).
BARMER Arzneimittelreport 2020. Sektorenübergreifende Arzneimitteltherapie. BARMER Verlag, Wuppertal 2020;

Link PDF

Grandt D, Lappe V, Schubert I (Hrsg.).
BARMER Arzneimittelreport 2019. Impfungen bei Kindern und Jugendlichen. BARMER Verlag, Wuppertal 2019;

Link PDF

Grandt D, Lappe V, Schubert I (Hrsg.).
Barmer Arzneimittelreport 2018. BARMER Verlag, Wuppertal 2018;

Link PDF

Grandt D, Schubert I (Hrsg.).
Barmer Arzneimittelreport 2017. Asgard Verlag, Siegburg. 2017;

Link PDF

Lappe V, Köster I, Schubert I.
Antidiabetische Medikation in den ersten vier Therapiejahren. Eine Studie auf Basis von Krankenkassendaten. Deutsche Medizinische Wochenschrift 2017; 142: e1-e9 und Diabetes Aktuell 2017; 15: 242-256

Link Abstract

Grandt D, Schubert I (Hrsg.).
Barmer GEK Arzneimittelreport 2016. Analysen zur Arzneimitteltherapie und Arzneimitteltherapiesicherheit. Band 39; Asgard Verlag, Siegburg. 2016;

Link PDF

Lappe V, Köster I, Schubert I.
Incidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data. International Journal of General Medicine 2013; 6: 135-144

Link Full Text

PMV

interdisciplinary team